This study is currently not recruiting participants.
Image One

A multicenter double-blind randomized withdrawal extension study of subcutaneous Secukinumab in prefilled syringes to demonstrate long-term efficacy safety and tolerability up to 2 years in subjects with moderate to severe chronic plaque-type psoriasis completing preceding psoriasis phase III studies with Secukinumab. CAIN457A2302E1

A multicenter double-blind randomized withdrawal extension study of subcutaneous Secukinumab in prefilled syringes to demonstrate long-term efficacy safety and tolerability up to 2 years in subjects with moderate to severe chronic plaque-type psoriasis completing preceding psoriasis phase III studies with Secukinumab. CAIN457A2302E1

Not Recruiting
1-99 years
All
Phase 3
Study details

816637

18 February 2024

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.